Literature DB >> 15848765

Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa.

Silvia Orenes Lorente1, Rosario Gómez, Carmen Jiménez, Simon Cammerer, Vanessa Yardley, Kate de Luca-Fradley, Simon L Croft, Luis M Ruiz Perez, Julio Urbina, Dolores Gonzalez Pacanowska, Ian H Gilbert.   

Abstract

In this paper we describe the preparation of some biphenylquinuclidine derivatives and their evaluation as inhibitors of squalene synthase in order to explore their potential in the treatment of the parasitic diseases leishmaniasis and Chagas disease. The compounds were screened against recombinant Leishmania major squalene synthase and against Leishmania mexicana promastigotes, Leishmania donovani intracellular amastigotes and Trypanosoma cruzi intracellular amastigotes. Compounds that inhibited the enzyme, also reduced the levels of steroids and caused growth inhibition of L. mexicana promastigotes. However there was a lower correlation between inhibition of the enzyme and growth inhibition of the intracellular parasites, possibly due to delivery problems. Some compounds also showed growth inhibition of T. brucei rhodesiense trypomastigotes, although in this case alternative modes of action other than inhibition of SQS are probably involved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848765     DOI: 10.1016/j.bmc.2005.02.060

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  12 in total

1.  Antiprotozoal activity of 1-phenethyl-4-aminopiperidine derivatives.

Authors:  Christophe Dardonville; Cristina Fernández-Fernández; Sarah-Louise Gibbons; Nadine Jagerovic; Lidia Nieto; Gary Ryan; Marcel Kaiser; Reto Brun
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

2.  Kinetic characterization of squalene synthase from Trypanosoma cruzi: selective inhibition by quinuclidine derivatives.

Authors:  Marco Sealey-Cardona; Simon Cammerer; Simon Jones; Luis M Ruiz-Pérez; Reto Brun; Ian H Gilbert; Julio A Urbina; Dolores González-Pacanowska
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

3.  Head-to-head prenyl tranferases: anti-infective drug targets.

Authors:  Fu-Yang Lin; Yi-Liang Liu; Kai Li; Rong Cao; Wei Zhu; Jordan Axelson; Ran Pang; Eric Oldfield
Journal:  J Med Chem       Date:  2012-05-01       Impact factor: 7.446

4.  In vitro activities of ER-119884 and E5700, two potent squalene synthase inhibitors, against Leishmania amazonensis: antiproliferative, biochemical, and ultrastructural effects.

Authors:  Juliany Cola Fernandes Rodrigues; Juan Luis Concepcion; Carlos Rodrigues; Aura Caldera; Julio A Urbina; Wanderley de Souza
Journal:  Antimicrob Agents Chemother       Date:  2008-09-02       Impact factor: 5.191

5.  Quinuclidine derivatives as potential antiparasitics.

Authors:  Simon B Cammerer; Carmen Jimenez; Simon Jones; Ludovic Gros; Silvia Orenes Lorente; Carlos Rodrigues; Juliany C F Rodrigues; Aura Caldera; Luis Miguel Ruiz Perez; Wanderley da Souza; Marcel Kaiser; Reto Brun; Julio A Urbina; Dolores Gonzalez Pacanowska; Ian H Gilbert
Journal:  Antimicrob Agents Chemother       Date:  2007-08-20       Impact factor: 5.191

6.  Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae.

Authors:  Simonetta Oliaro-Bosso; Maurizio Ceruti; Gianni Balliano; Paola Milla; Flavio Rocco; Franca Viola
Journal:  Lipids       Date:  2005-12       Impact factor: 1.880

7.  Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis.

Authors:  Kelly Ishida; Juliany Cola Fernandes Rodrigues; Simon Cammerer; Julio A Urbina; Ian Gilbert; Wanderley de Souza; Sonia Rozental
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-01-21       Impact factor: 3.944

8.  Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.

Authors:  Wanderley de Souza; Juliany Cola Fernandes Rodrigues
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-05

9.  Developments in diagnosis and antileishmanial drugs.

Authors:  Prachi Bhargava; Rajni Singh
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-18

Review 10.  Synthetic Medicinal Chemistry in Chagas' Disease: Compounds at The Final Stage of "Hit-To-Lead" Phase.

Authors:  Hugo Cerecetto; Mercedes González
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.